MarketPeel
Insider Trading Intelligence
WM

Walter H. Moos

RIGL
DIRECTOR · RIGEL PHARMACEUTICALS INC · CIK 0001190272
FILING MIX · LIFETIME85%/15%
BUYS
11
SELLS
2
TOTAL VALUE
$241.4K
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
18,472
AVG SELL PX
$36.36
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Walter H. Moos, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-2.03%-0.50%-1.53%-1.53%
14d1+100.00%-18.58%-2.47%-16.11%-16.11%
30d1+100.00%-25.27%-4.94%-20.33%-20.33%
60d1+100.00%-8.94%+2.13%-11.06%-11.06%
90d1+100.00%-19.32%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RIGL · 18,472 shares · as of May 15, 2026
025,55651,11176,667102,222202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 2 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,75018,472May 15, 2026May 19, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
4,000$36.36$145.4K12,722Feb 20, 2026Feb 24, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
4,000$24.00$96.0K16,722Feb 20, 2026Feb 24, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
4,0000Feb 20, 2026Feb 24, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,0003,000May 23, 2025May 28, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,50012,722May 23, 2025May 28, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
25,000102,222May 25, 2024May 29, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,00030,000May 25, 2024May 29, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
25,00052,222May 20, 2022May 23, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,00030,000May 20, 2022May 23, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,00030,000May 19, 2021May 21, 2021View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
25,00027,222May 19, 2021May 21, 2021View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
55,00055,000May 15, 2020May 15, 2020View →
Other insiders · RIGL
Loading peer insiders…
About this filer
CIK 0001190272
ROLE
Director
PRIMARY
RIGL
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001190272DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback